MedTrace Logo

Body Awareness Therapy and Biomarkers in Fibromyalgia

NCT05555394 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2025-05-08

No results posted yet for this study

Summary

A randomized trial of Basic Body Awareness Therapy (BBAT) is applied in fibromyalgia patients as compared with a control intervention consisting of stretching. Sessions of BBAT lasted 90 min each and took place twice a week form 12 weeks. The primary end point is a change in the biomarkers and neurotransmitters and the Fibromyalgia Impact Questionnaire and the secondary end points include Visual Analog Scale, State Trait Anxiety inventory, Beck Depression Inventory. All assessments will be repeated at post treatment, 12 and 24 weeks and 1 year follow-up.

Conditions

  • Fibromyalgia

Interventions

OTHER

Basic Body Awareness Therapy

The intervention will be twice a week during 12 weeks. It lasts 90 min of movements of daily life, massage and self-reflections.

OTHER

Stretching Exercise

It consists in stretching movements of whole body

Sponsors & Collaborators

  • Consorci Sanitari de l'Anoia

    collaborator OTHER

  • Universitat de Lleida

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-08
Primary Completion
2025-05-01
Completion
2025-09-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05555394 on ClinicalTrials.gov